HERON THERAPEUTICS, INC. /DE/ (HRTX) Lessee, Operating Lease, Liability, to be Paid USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Heron Therapeutics, Inc. /De/ quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from 2019 to 2024.
  • Heron Therapeutics, Inc. /De/ Lessee, Operating Lease, Liability, to be Paid for the quarter ending March 31, 2024 was $5.5 M, a 34.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $5.5 M -$2.86 M -34.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $6.29 M -$2.81 M -30.8% Dec 31, 2023 10-K 2024-03-12
Q3 2023 $7.06 M -$2.76 M -28.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $7.37 M -$3.17 M -30.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $8.36 M -$2.91 M -25.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $9.1 M -$2.89 M -24.1% Dec 31, 2022 10-K 2023-03-29
Q3 2022 $9.83 M -$8.06 M -45% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $10.5 M -$8.32 M -44.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $11.3 M -$8.58 M -43.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $12 M -$8.85 M -42.5% Dec 31, 2021 10-K 2022-02-28
Q3 2021 $17.9 M -$3.91 M -18% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $18.9 M -$3.89 M -17.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $19.8 M -$3.86 M -16.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $20.8 M +$3.32 M +19% Dec 31, 2020 10-K 2021-02-24
Q3 2020 $21.8 M +$6.63 M +43.7% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $22.8 M +$6.86 M +43.2% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $23.7 M +$6.8 M +40.2% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $17.5 M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $15.2 M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $15.9 M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $16.9 M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.